Tennessee Biotechnology Association | Membership

Glenveigh Medical, LLC
Rick Proctor ,Jr.
423/933-3939
rick.proctir@glenveigh.com

401 Chestnut St., Suite 230
Chattanooga, TN 37402

Secondary contact information:
VP Operations Jeff Smith
Email:jeff.smith@glenveigh.com
Company Description:
Glenveigh Medical is a science and technology-based company focused on advancing the practice of obstetrics, with aspirations to rapidly become the leader in the field. Glenveigh Pharmaceuticals was formed in 2004 as the platform for this vision and to fulfill almost 10 years of prior research by the founder, C. David Adair, MD, a maternal-fetal medicine (MFM) specialist. Dr. Adair’s early work with a GlaxoSmithKline (GSK) drug, Digibind®, led to the initiation of a Phase IIb clinical trial in pregnant women (the DEEP Study) to test the efficacy for severe preeclampsia. This study has been completed with positive results, and plans for the next trial are being formulated. In addition to Glenveigh Pharmaceuticals, the Glenveigh Medical group of companies now includes Glenveigh Surgical (instruments and devices) and Glenveigh Research.

www.glenveigh.com

Membership Directory

Board of Directors

Academic Chapter

This website managed by Iostudio